Zinnia Wealth Advisory »

Catalyst Pharmaceutical Partners shares owned by Zinnia Wealth Advisory

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Zinnia Wealth Advisory from 13F filings

Historical chart of Zinnia Wealth Advisory investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Zinnia Wealth Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Zinnia Wealth Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $548k 22k 24.76

More positions owned by Zinnia Wealth Advisory

Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPMD)
Spdr Index Shs Fds State Street Spd (SPEM)
Spdr Series Trust State Street Spd (SPTS)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust State Street Spd (SPTI)
Spdr Series Trust State Street Spd (SPSM)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPSB)
Wal-Mart Stores (WMT)

View all positions for Zinnia Wealth Advisory

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Fundsmith
Bank of America Corporation
American Century Companies
Geode Capital Management
Morgan Stanley
Renaissance Technologies
Vanguard Portfolio Management
Royce & Associates
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners